Cis-platinum vestibular toxicity
Open Access
- 28 February 1981
- Vol. 47 (5) , 857-859
- https://doi.org/10.1002/1097-0142(19810301)47:5<857::aid-cncr2820470508>3.0.co;2-m
Abstract
Cis‐diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported. Cancer 47:857–8589, 1981.This publication has 6 references indexed in Scilit:
- cis-Platinum OtotoxicityClinical Toxicology, 1978
- Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pigToxicology and Applied Pharmacology, 1975
- Degenerative Changes in the Human Vestibular Sensory EpitheliaActa Oto-Laryngologica, 1975
- Sensory and Neural Degeneration with Aging, as Seen in Microdissections of the Human Inner EarAnnals of Otology, Rhinology & Laryngology, 1972
- Streptomycin Sulfate in the Management of Meniere’s DiseaseOtolaryngologic Clinics of North America, 1968
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965